Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Invernizzi

Showing results (311-320 of 420) with videos related to

Pageof 42
Sort By:
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 7, 2019
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cellsAlessandra Gentilini, Alessandra Caligiuri, Chiara Raggi, et al.
Journal of Autoimmunity|June 18, 2020
Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitisXing Zhou, Muchena J Kailemia, Ying Sun, et al.
Journal of Autoimmunity|February 12, 2013
Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouseYugo Ando, Guo-Xiang Yang, Thomas P Kenny, et al.
Autoimmunity Reviews|November 3, 2015
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 yearsCarlo Selmi, Angela Ceribelli, Elena Generali, et al.
Journal of Clinical Medicine|May 14, 2022
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence?Sara Massironi, Roberta Elisa Rossi, Anna Caterina Milanetto, et al.
BMJ Open|January 9, 2026
Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trialLaura Cristoferi, Daphne D'Amato, Cesare Maino, et al.
Hepatology Communications|May 16, 2018
NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acidKathy L de Graaf, Geneviève Lapeyre, Florence Guilhot, et al.
Journal of Hepatology|September 6, 2016
Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophagesChiara Raggi, Margherita Correnti, Antonio Sica, et al.
JHEP Reports : Innovation in Hepatology|October 21, 2022
Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitisDiletta Overi, Guido Carpino, Laura Cristoferi, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 21, 2019
Pinealectomy or light exposure exacerbates biliary damage and liver fibrosis in cholestatic rats through decreased melatonin synthesisLixian Chen, Tianhao Zhou, Nan Wu, et al.
Pageof 42

Showing results (311-320 of 420) with videos related to

Sort By:
Pageof 42
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 7, 2019
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cellsAlessandra Gentilini, Alessandra Caligiuri, Chiara Raggi, et al.
Journal of Autoimmunity|June 18, 2020
Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitisXing Zhou, Muchena J Kailemia, Ying Sun, et al.
Journal of Autoimmunity|February 12, 2013
Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouseYugo Ando, Guo-Xiang Yang, Thomas P Kenny, et al.
Autoimmunity Reviews|November 3, 2015
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 yearsCarlo Selmi, Angela Ceribelli, Elena Generali, et al.
Journal of Clinical Medicine|May 14, 2022
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence?Sara Massironi, Roberta Elisa Rossi, Anna Caterina Milanetto, et al.
BMJ Open|January 9, 2026
Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trialLaura Cristoferi, Daphne D'Amato, Cesare Maino, et al.
Hepatology Communications|May 16, 2018
NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acidKathy L de Graaf, Geneviève Lapeyre, Florence Guilhot, et al.
Journal of Hepatology|September 6, 2016
Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophagesChiara Raggi, Margherita Correnti, Antonio Sica, et al.
JHEP Reports : Innovation in Hepatology|October 21, 2022
Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitisDiletta Overi, Guido Carpino, Laura Cristoferi, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 21, 2019
Pinealectomy or light exposure exacerbates biliary damage and liver fibrosis in cholestatic rats through decreased melatonin synthesisLixian Chen, Tianhao Zhou, Nan Wu, et al.
Pageof 42